☰

Lisa M. Guerrettaz, Ph.D. - Publications

Affiliations: 
2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology, Aging
Tree Info Grants Similar researchers PubMed Report error

5/9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Clarke R, Kim W, Groff B, Abujarour R, Robinson M, Huang X, Sahaf N, Raynel S, Rezner B, Robbins D, Guerrettaz L, Shoemaker D, Valamehr B. A Platform for the Scalable Derivation of Genetically-Enhanced T and NK Lymphocytes from Naive Human Induced Pluripotent Stem Cells for Cancer Immunotherapy Blood. 126: 2364-2364. DOI: 10.1182/Blood.V126.23.2364.2364  0.445
2015 Guerrettaz L, Sahaf N, Mitchell L, Lynn C, Raynel S, Le T, Foster H, Truong C, Rezner B, Robbins D, Levin WJ, Shoemaker D. Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality Blood. 126: 1884-1884. DOI: 10.1182/BLOOD.V126.23.1884.1884  0.406
2014 Robbins D, Le T, Troung C, Foster H, Rezner B, Mitchell L, Guerrettaz L, Multani PS, Shoemaker D. Ex Vivo Modulation of Mobilized Peripheral Blood: Characterization of HSC and T-Cell Responses to Prostaglandin E2 Blood. 124: 1092-1092. DOI: 10.1182/BLOOD.V124.21.1092.1092  0.392
2011 Lukin K, Fields S, Guerrettaz L, Straign D, Rodriguez V, Zandi S, Månsson R, Cambier JC, Sigvardsson M, Hagman J. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. European Journal of Immunology. 41: 1787-93. PMID 21469119 DOI: 10.1002/Eji.201041137  0.42
2008 Guerrettaz LM, Johnson SA, Cambier JC. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proceedings of the National Academy of Sciences of the United States of America. 105: 11898-902. PMID 18697924 DOI: 10.1073/Pnas.0805498105  0.422
Low-probability matches (unlikely to be authored by this person)
2014 Cutler CS, Shoemaker D, Westervelt P, Couriel DR, Vasu S, Isola LM, Karanes C, Newell L, Rezner B, Guerrettaz L, Robbins D, Medcalf A, Wolchko S, Ferraro J, Multani PS. Ex Vivo Pharmacologic Modulation in a Nutrient-Rich Medium to Accelerate Engraftment of Human Umbilical Cord Blood Blood. 124: 3807-3807. DOI: 10.1182/blood.V124.21.3807.3807  0.296
2016 Guerrettaz L, Sahaf N, Meza M, Hardy I, Lynn C, Raynel S, Le T, Foster H, Rezner B, Robbins D, Shoemaker D. Ex Vivo Programming of Donor Cells Prior to Allo-HCT Reduces Gvhd without Compromising GVL Biology of Blood and Marrow Transplantation. 22: S396. DOI: 10.1016/j.bbmt.2015.11.920  0.277
2022 Ben Nasr M, Robbins D, Parone P, Usuelli V, Tacke R, Seelam AJ, Driver E, Le T, Sabouri-Ghomi M, Guerrettaz L, Shoemaker D, Fiorina P. Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders. Journal of Immunology (Baltimore, Md. : 1950). 208: 1554-1565. PMID 35321879 DOI: 10.4049/jimmunol.2100949  0.277
2018 Guerrettaz L, Hosking M, Maine C, Sahaf N, Fremgen D, Schendel C, Boyett M, Sabouri-Ghomi M, Robbins D, Shoemaker D. Protmune Reduces the Incidence and Severity of Acute Gvhd by Transiently Dampening T-Cell Signaling Biology of Blood and Marrow Transplantation. 24: S199-S200. DOI: 10.1016/J.BBMT.2017.12.160  0.202
Hide low-probability matches.